Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Eur J Heart Fail

Retrieve available abstracts of 368 articles:
HTML format
Text format



Single Articles


    May 2017
  1. VEGTER EL, van der Meer P, Voors AA
    Associations between volume status and circulating microRNAs in acute heart failure.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  2. CHIRINOS JA, Londono-Hoyos F, Zamani P, Beraun M, et al
    Effects of organic and inorganic nitrate on aortic and carotid haemodynamics in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  3. POPESCU BA, Beladan CC, Popescu AC
    Mechanical dyssynchrony in heart failure with preserved ejection fraction: a treatment target or a dead end?
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  4. METRA M, Ravera A, Filippatos G
    Understanding worsening heart failure as a therapeutic target: another step forward?
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  5. PASCUAL-FIGAL DA
    Acute heart failure and biomarkers: time also matters, don't relax.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  6. VADUGANATHAN M, Patel RB, Butler J, Metra M, et al
    Integrating electronic health records into the study of heart failure: promises and pitfalls.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  7. VAN AELST LNL, Abraham M, Sadoune M, Lefebvre T, et al
    Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up.
    Eur J Heart Fail. 2017 May 17. doi: 10.1002.
    PubMed     Text format    


  8. EDELMANN F, Bobenko A, Gelbrich G, Hasenfuss G, et al
    Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial.
    Eur J Heart Fail. 2017 May 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  9. MORBACH C, Marx A, Kaspar M, Guder G, et al
    Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
    Eur J Heart Fail. 2017 May 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  10. PINTALHAO M, Castro-Chaves P, Bettencourt P
    Are circulating relaxin levels related to pulmonary hypertension in patients with heart failure? A reply.
    Eur J Heart Fail. 2017 May 4. doi: 10.1002.
    PubMed     Text format    


  11. MAMAS MA, Sperrin M, Watson MC, Coutts A, et al
    Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland.
    Eur J Heart Fail. 2017 May 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  12. GREENE SJ, Vaduganathan M, Gheorghiade M
    Finding the road to recovery: therapeutic and clinical trial implications of dysfunctional viable myocardium in heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2017 May 2. doi: 10.1002.
    PubMed     Text format    



  13. Abstracts of the Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, Paris, France, 29 April - 2 May 2017.
    Eur J Heart Fail. 2017;19 Suppl 1:5-601.
    PubMed     Text format    


  14. AHMAD T, Testani JM
    What happens to stable heart failure patients when they don't take their medicines?
    Eur J Heart Fail. 2017;19:650-651.
    PubMed     Text format    


  15. NAGELE MP
    Pulmonary artery pressure-based telemedicine in heart failure: ready for Europe?
    Eur J Heart Fail. 2017;19:670-672.
    PubMed     Text format    


    April 2017
  16. KOMAJDA M, Cowie MR, Tavazzi L, Ponikowski P, et al
    Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Eur J Heart Fail. 2017 Apr 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  17. CHIONCEL O, Mebazaa A, Harjola VP, Coats AJ, et al
    Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2017 Apr 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  18. KOMAJDA M, Isnard R, Cohen-Solal A, Metra M, et al
    Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Eur J Heart Fail. 2017 Apr 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  19. TEERLINK JR, Voors AA, Ponikowski P, Pang PS, et al
    Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Eur J Heart Fail. 2017 Apr 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  20. ANKER SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, et al
    Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
    Eur J Heart Fail. 2017 Apr 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  21. VINEREANU D, Margulescu AD
    The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction: add global longitudinal strain to the list.
    Eur J Heart Fail. 2017 Apr 19. doi: 10.1002.
    PubMed     Text format    


  22. FERREIRA JP, Mentz RJ, Pizard A, Pitt B, et al
    Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?
    Eur J Heart Fail. 2017 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  23. HULOT JS, Salem JE, Redheuil A, Collet JP, et al
    Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.
    Eur J Heart Fail. 2017 Apr 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  24. LUPON J, Diez-Lopez C, de Antonio M, Domingo M, et al
    Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Eur J Heart Fail. 2017 Apr 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  25. CHIONCEL O, Lainscak M, Seferovic PM, Anker SD, et al
    Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2017 Apr 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  26. TKACZYSZYN M, Comin-Colet J, Voors AA, van Veldhuisen DJ, et al
    Iron deficiency and red cell indices in patients with heart failure.
    Eur J Heart Fail. 2017 Apr 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  27. VENTURA HO, Messerli FH, Lavie CJ
    Observations on the blood pressure paradox in heart failure.
    Eur J Heart Fail. 2017 Apr 3. doi: 10.1002.
    PubMed     Text format    


  28. LYONS OD, Floras JS, Logan AG, Beanlands R, et al
    Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial.
    Eur J Heart Fail. 2017;19:579-587.
    PubMed     Text format     Abstract available


  29. DEFTEREOS S, Giannopoulos G, Panagopoulou V, Filippatos G, et al
    Surrogate endpoints in heart failure: (once again) use with caution.
    Eur J Heart Fail. 2017;19:563-565.
    PubMed     Text format    


    March 2017
  30. ROM O, Aviram M
    High-density lipoprotein-associated paraoxonase 1: a possible prognostic biomarker for heart failure?
    Eur J Heart Fail. 2017 Mar 31. doi: 10.1002.
    PubMed     Text format    


  31. TSUJI K, Sakata Y, Nochioka K, Miura M, et al
    Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
    Eur J Heart Fail. 2017 Mar 31. doi: 10.1002.
    PubMed     Text format     Abstract available


  32. LOFMAN I, Szummer K, Dahlstrom U, Jernberg T, et al
    Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Eur J Heart Fail. 2017 Mar 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  33. MONTERO D, Flammer AJ
    Exercise intolerance in heart failure with preserved ejection fraction: time to scrutinize diuretic therapy?
    Eur J Heart Fail. 2017 Mar 29. doi: 10.1002.
    PubMed     Text format    


  34. SCHMID FA, Schlager O, Keller P, Seifert B, et al
    Prognostic value of long-term blood pressure changes in patients with chronic heart failure.
    Eur J Heart Fail. 2017 Mar 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  35. COWIE MR, Filippatos GS, Alonso Garcia ML, Anker SD, et al
    New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.
    Eur J Heart Fail. 2017 Mar 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  36. DEVAUX Y, Creemers EE, Boon RA, Werfel S, et al
    Circular RNAs in heart failure.
    Eur J Heart Fail. 2017 Mar 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  37. PIEPOLI MF
    Obesity in heart failure: is it time to rethink the paradox?
    Eur J Heart Fail. 2017 Mar 24. doi: 10.1002.
    PubMed     Text format    


  38. D'ELIA E, Iacovoni A, Vaduganathan M, Lorini FL, et al
    Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.
    Eur J Heart Fail. 2017 Mar 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  39. BIERING-SORENSEN T, Shah SJ, Anand I, Sweitzer N, et al
    Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Mar 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  40. MCDONALD K, O'Hanlon R, Savage HO, Khushaba RN, et al
    Sleep-disordered breathing in chronic heart failure is highly variable when measured remotely using a novel non-contact biomotion sensor.
    Eur J Heart Fail. 2017 Mar 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  41. OLIVIER A, Pitt B, Girerd N, Lamiral Z, et al
    Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.
    Eur J Heart Fail. 2017 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  42. SHARMA K, Fang JC
    The heart-kidney relationship in heart failure: it's not you, it's me.
    Eur J Heart Fail. 2017 Mar 15. doi: 10.1002.
    PubMed     Text format    


  43. RICKENBACHER P, Kaufmann BA, Maeder MT, Bernheim A, et al
    Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Eur J Heart Fail. 2017 Mar 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  44. DOVANCESCU S, Pellicori P, Mabote T, Torabi A, et al
    The effects of short-term omission of daily medication on the pathophysiology of heart failure.
    Eur J Heart Fail. 2017 Mar 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  45. CLELAND JG, Teerlink JR, Davison BA, Shoaib A, et al
    Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studie
    Eur J Heart Fail. 2017 Mar 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  46. SLIWA K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, et al
    Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM.
    Eur J Heart Fail. 2017 Mar 8. doi: 10.1002.
    PubMed     Text format     Abstract available



  47. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
    Eur J Heart Fail. 2017;19:438.
    PubMed     Text format    


  48. DIERCKX R, Inglis SC, Clark RA, Prieto-Merino D, et al
    Telemedicine in heart failure: new insights from the Cochrane meta-analyses.
    Eur J Heart Fail. 2017;19:304-306.
    PubMed     Text format    


  49. PAN A
    The real-world evidence of heart failure co-morbidities.
    Eur J Heart Fail. 2017;19:434.
    PubMed     Text format    


  50. BRISTOW MR
    Genetic variation expressed in the brain may impact heart failure.
    Eur J Heart Fail. 2017;19:324-325.
    PubMed     Text format    


  51. MCDONALD K, Gallagher J
    The practice gap in heart failure-the elephant in the room.
    Eur J Heart Fail. 2017;19:301-303.
    PubMed     Text format    


  52. MAASS AH, DeJongste MJ, van der Meer P
    Neuromodulation for systolic heart failure: more than a placebo effect?
    Eur J Heart Fail. 2017;19:401-403.
    PubMed     Text format    



  53. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2017;19:437.
    PubMed     Text format    


  54. DEMISSEI BG, Postmus D, Cleland JG, O'Connor CM, et al
    Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.
    Eur J Heart Fail. 2017 Mar 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  55. VOORS AA, Ouwerkerk W, Zannad F, van Veldhuisen DJ, et al
    Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure.
    Eur J Heart Fail. 2017 Mar 1. doi: 10.1002.
    PubMed     Text format     Abstract available


    February 2017
  56. EMMENS JE, Ter Maaten JM, Voors AA
    Are circulating relaxin levels related to pulmonary hypertension in patients with heart failure?
    Eur J Heart Fail. 2017 Feb 28. doi: 10.1002.
    PubMed     Text format    


  57. PELLICORI P, Urbinati A, Shah P, MacNamara A, et al
    What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?
    Eur J Heart Fail. 2017 Feb 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  58. PAOLILLO S, Mapelli M, Bonomi A, Corra U, et al
    Prognostic role of beta-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.
    Eur J Heart Fail. 2017 Feb 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  59. VAN SPALL HG, Rahman T, Mytton O, Ramasundarahettige C, et al
    Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis.
    Eur J Heart Fail. 2017 Feb 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  60. LUND LH, Carrero JJ, Farahmand B, Henriksson KM, et al
    Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study.
    Eur J Heart Fail. 2017 Feb 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  61. PARASKEVAIDIS IA, Ikonomidis I, Simitsis P, Parissis J, et al
    Multidimensional contractile reserve predicts adverse outcome in patients with severe systolic heart failure: a 4-year follow-up study.
    Eur J Heart Fail. 2017 Feb 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  62. NAYOR M, Larson MG, Wang N, Santhanakrishnan R, et al
    The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.
    Eur J Heart Fail. 2017 Feb 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  63. GUSTAFSSON F, Rogers JG
    Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.
    Eur J Heart Fail. 2017 Feb 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  64. SCALI MC, Cortigiani L, Simionuc A, Gregori D, et al
    Exercise-induced B-lines identify worse functional and prognostic stage in heart failure patients with depressed left ventricular ejection fraction.
    Eur J Heart Fail. 2017 Feb 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  65. EMDIN M, Aimo A, Passino C, Vergaro G, et al
    Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly?
    Eur J Heart Fail. 2017 Feb 15. doi: 10.1002.
    PubMed     Text format    


  66. DEVORE AD, McNulty S, Alenezi F, Ersboll M, et al
    Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
    Eur J Heart Fail. 2017 Feb 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  67. HAMMADAH M, Kalogeropoulos AP, Georgiopoulou VV, Weber M, et al
    High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.
    Eur J Heart Fail. 2017 Feb 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  68. COWIE MR, Simon M, Klein L, Thokala P, et al
    The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.
    Eur J Heart Fail. 2017 Feb 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  69. LUND LH, Braunschweig F, Benson L, Stahlberg M, et al
    Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry.
    Eur J Heart Fail. 2017 Feb 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  70. HARJOLA P, Tolonen J, Boyd J, Mattila J, et al
    The role of pre-hospital management in acute heart failure.
    Eur J Heart Fail. 2017;19:287-289.
    PubMed     Text format    


  71. STEWART COATS AJ
    Early abnormalities of cerebral blood flow in mild non-ischaemic heart failure: part of a whole-body response?
    Eur J Heart Fail. 2017;19:269-270.
    PubMed     Text format    


  72. NAAR J, Jaye D, Linde C, Neuzil P, et al
    Spinal cord stimulation in heart failure: effect on disease-associated biomarkers.
    Eur J Heart Fail. 2017;19:283-286.
    PubMed     Text format    


  73. METRA M
    February 2017 at a glance: fibrosis, acute heart failure and neurologic abnormalities.
    Eur J Heart Fail. 2017;19:165-166.
    PubMed     Text format    


  74. AHMAD T, Testani JM
    Haemoconcentration as a treatment goal in heart failure: ready for prime time?
    Eur J Heart Fail. 2017;19:237-240.
    PubMed     Text format    


    January 2017
  75. DEMISSEI BG, Cotter G, Prescott MF, Felker GM, et al
    A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  76. SOKOLSKI M, Zymlinski R, Biegus J, Siwolowski P, et al
    Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  77. PAPADAKI A, Martinez-Gonzalez MA, Alonso-Gomez A, Rekondo J, et al
    Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  78. GRUSON D, Pouleur AC, Makris K, Chrysohoou C, et al
    Systematic vitamin D supplementation and monitoring: improving outcomes in heart failure?
    Eur J Heart Fail. 2017 Jan 24. doi: 10.1002.
    PubMed     Text format    


  79. DE KEULENAER GW, Segers VF, Zannad F, Brutsaert DL, et al
    The future of pleiotropic therapy in heart failure. Lessons from the benefits of exercise training on endothelial function.
    Eur J Heart Fail. 2017 Jan 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  80. TER MAATEN JM, Rao VS, Hanberg JS, Perry Wilson F, et al
    Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure.
    Eur J Heart Fail. 2017 Jan 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  81. GUAZZI M, van Heerebeek L, Paulus WJ
    Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention.
    Eur J Heart Fail. 2017 Jan 19. doi: 10.1002.
    PubMed     Text format    


  82. KOMAJDA M
    Liraglutide in heart failure: caution is needed.
    Eur J Heart Fail. 2017;19:78-79.
    PubMed     Text format    


  83. EZEKOWITZ JA, Armstrong PW
    Diabetes and heart failure in the crosshairs: where is the target?
    Eur J Heart Fail. 2017;19:66-68.
    PubMed     Text format    


  84. GWIZDALA A, Rozwadowska N, Kolanowski TJ, Malcher A, et al
    Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure.
    Eur J Heart Fail. 2017;19:148-157.
    PubMed     Text format     Abstract available


    December 2016
  85. KOUDSTAAL S, Pujades-Rodriguez M, Denaxas S, Gho JM, et al
    Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people.
    Eur J Heart Fail. 2016 Dec 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  86. FARMAKIS D, Triposkiadis F, Lekakis J, Parissis J, et al
    Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management.
    Eur J Heart Fail. 2016 Dec 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  87. MATYAS C, Nemeth BT, Olah A, Torok M, et al
    Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
    Eur J Heart Fail. 2016 Dec 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  88. ANGERMANN CE, Kaspar M, Marx A, Kittel-Schneider S, et al
    A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study.
    Eur J Heart Fail. 2016 Dec 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  89. BUNDGAARD H, Axelsson A, Hartvig Thomsen J, Sorgaard M, et al
    The-first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial.
    Eur J Heart Fail. 2016 Dec 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  90. SABBAH HN
    Silent disease progression in clinically stable heart failure.
    Eur J Heart Fail. 2016 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  91. SILVESTRE OM, Goncalves A, Nadruz W Jr, Claggett B, et al
    Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study.
    Eur J Heart Fail. 2016 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  92. CLELAND JG
    Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably!
    Eur J Heart Fail. 2016 Dec 11. doi: 10.1002.
    PubMed     Text format    


  93. BOHM M
    Heart rate: from heart failure to chronic diseases and cancer. Is there a role for supportive care by heart rate reduction?
    Eur J Heart Fail. 2016 Dec 4. doi: 10.1002.
    PubMed     Text format    


  94. VON HAEHLING S, Papp Z, Anker SD
    ESC Heart Failure: a new journal aims to broaden heart failure views.
    Eur J Heart Fail. 2016;18:1415-1419.
    PubMed     Text format    


    November 2016
  95. DUCA F, Zotter-Tufaro C, Kammerlander AA, Panzenbock A, et al
    Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure.
    Eur J Heart Fail. 2016 Nov 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  96. REDDY YN, Borlaug BA
    Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 Nov 21. doi: 10.1002.
    PubMed     Text format    


  97. LIU LC, Hummel YM, van der Meer P, Berger RM, et al
    Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension.
    Eur J Heart Fail. 2016 Nov 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  98. ROSSIGNOL P, Girerd N, Bakris G, Vardeny O, et al
    Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.
    Eur J Heart Fail. 2016 Nov 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  99. CANNON JA, Shen L, Jhund PS, Kristensen SL, et al
    Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2016 Nov 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  100. GORTER TM, Rienstra M, van Veldhuisen DJ
    Right ventricular dysfunction in heart failure with reduced vs. preserved ejection fraction: non-identical twins?
    Eur J Heart Fail. 2016 Nov 17. doi: 10.1002.
    PubMed     Text format    


  101. GHIO S, Guazzi M, Scardovi AB, Klersy C, et al
    Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.
    Eur J Heart Fail. 2016 Nov 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  102. ERKELENS CD, van der Wal HH, de Jong BM, Elting JW, et al
    Dynamics of cerebral blood flow in patients with mild non-ischaemic heart failure.
    Eur J Heart Fail. 2016 Nov 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  103. PACKER M, Holcomb R, Abraham WT, Anker S, et al
    Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure.
    Eur J Heart Fail. 2016 Nov 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  104. HEGGERMONT WA, Papageorgiou AP, Heymans S, van Bilsen M, et al
    Metabolic support for the heart: complementary therapy for heart failure?
    Eur J Heart Fail. 2016 Nov 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  105. PARISSIS J, Nikolaou M, Mebazaa A
    The Model for End-stage Liver Disease score in acute heart failure: hepatorenal dysfunction hides behind.
    Eur J Heart Fail. 2016 Nov 4. doi: 10.1002.
    PubMed     Text format    


  106. KAJIMOTO K, Takano T
    Role of functional mitral regurgitation in heart failure with preserved ejection fraction: an unrecognized protagonist?: reply.
    Eur J Heart Fail. 2016 Nov 4. doi: 10.1002.
    PubMed     Text format    


  107. TRIPOSKIADIS F, Pieske B, Butler J, Parissis J, et al
    Global left atrial failure in heart failure.
    Eur J Heart Fail. 2016;18:1307-1320.
    PubMed     Text format     Abstract available


  108. JHUND PS
    Geographic variation in heart failure-a matter of celebration or condemnation?
    Eur J Heart Fail. 2016;18:1329-1330.
    PubMed     Text format    


  109. METRA M
    November 2016 at a glance: the left atrium, screening for heart failure, multimodality imaging for cardiac resynchronization therapy.
    Eur J Heart Fail. 2016;18:1305-1306.
    PubMed     Text format    


  110. MEIJERS WC, de Boer RA, Ho JE
    Biomarkers to identify and prevent new-onset heart failure in the community.
    Eur J Heart Fail. 2016;18:1351-1352.
    PubMed     Text format    


  111. YANG H, Negishi K, Wang Y, Nolan M, et al
    Echocardiographic screening for non-ischaemic stage B heart failure in the community.
    Eur J Heart Fail. 2016;18:1331-1339.
    PubMed     Text format     Abstract available


  112. HAUGAA KH, Edvardsen T
    Global longitudinal strain: the best biomarker for predicting prognosis in heart failure?
    Eur J Heart Fail. 2016;18:1340-1341.
    PubMed     Text format    


    October 2016
  113. ARRIGO M, Gayat E, Parenica J, Ishihara S, et al
    Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry.
    Eur J Heart Fail. 2016 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  114. TARGHER G, Dauriz M, Laroche C, Temporelli PL, et al
    In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2016 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  115. JORSAL A, Kistorp C, Holmager P, Tougaard RS, et al
    Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
    Eur J Heart Fail. 2016 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  116. COIRO S, Girerd N, Rossignol P, Ferreira JP, et al
    Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myoc
    Eur J Heart Fail. 2016 Oct 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  117. DIEZ J
    Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy.
    Eur J Heart Fail. 2016 Oct 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  118. MEIJERS WC, van der Velde AR, Muller Kobold AC, Dijck-Brouwer J, et al
    Variability of biomarkers in patients with chronic heart failure and healthy controls.
    Eur J Heart Fail. 2016 Oct 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  119. KLIP IT, Voors AA, Swinkels DW, Bakker SJ, et al
    Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community.
    Eur J Heart Fail. 2016 Oct 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  120. BREIDTHARDT T, Weidmann ZM, Twerenbold R, Gantenbein C, et al
    Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function.
    Eur J Heart Fail. 2016 Oct 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  121. GREENE SJ, Fonarow GC, Solomon SD, Subacius HP, et al
    Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.
    Eur J Heart Fail. 2016 Oct 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  122. OBOKATA M, Borlaug BA
    Right ventricular dysfunction and pulmonary hypertension in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 Oct 13. doi: 10.1002.
    PubMed     Text format    


  123. BIEGUS J, Zymlinski R, Sokolski M, Siwolowski P, et al
    Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.
    Eur J Heart Fail. 2016 Oct 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  124. METRA M
    October 2016 at a glance: treatment of heart failure.
    Eur J Heart Fail. 2016;18:1209-1210.
    PubMed     Text format    


  125. VADUGANATHAN M, Patel RB, Yancy CW
    Stroke prevention in heart failure and sinus rhythm: where do we go from here?
    Eur J Heart Fail. 2016;18:1267-1269.
    PubMed     Text format    


  126. CHAGGAR PS, Williams SG, Yonan N, Fildes J, et al
    Myocardial recovery with mechanical circulatory support.
    Eur J Heart Fail. 2016;18:1220-1227.
    PubMed     Text format     Abstract available


  127. REGOLI F, Bongiorni MG, Rordorf R, Santamaria M, et al
    High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.
    Eur J Heart Fail. 2016;18:1270-1277.
    PubMed     Text format     Abstract available


    September 2016
  128. FITCHETT DH, Udell JA, Inzucchi SE
    Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.
    Eur J Heart Fail. 2016 Sep 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  129. GORTER TM, Hoendermis ES, van Veldhuisen DJ, Voors AA, et al
    Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  130. NIEWINSKI P, Janczak D, Rucinski A, Tubek S, et al
    Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  131. DINI FL, Carluccio E, Simioniuc A, Biagioli P, et al
    Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  132. ADAMO L, Nassif ME, Novak E, LaRue SJ, et al
    Prevalence of lactic acidaemia in patients with advanced heart failure and depressed cardiac output.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  133. MARTINSON M, Bharmi R, Dalal N, Abraham WT, et al
    Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial.
    Eur J Heart Fail. 2016 Sep 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  134. MELENOVSKY V, Petrak J, Mracek T, Benes J, et al
    Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis.
    Eur J Heart Fail. 2016 Sep 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  135. SANTAS E, Nunez E, Nunez J
    Role of functional mitral regurgitation in heart failure with preserved ejection fraction: an unrecognized protagonist?
    Eur J Heart Fail. 2016 Sep 19. doi: 10.1002.
    PubMed     Text format    


  136. ADAMSON PB, Ginn G, Anker SD, Bourge RC, et al
    Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials.
    Eur J Heart Fail. 2016 Sep 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  137. KITAI T, Grodin JL, Mentz RJ, Hernandez AF, et al
    Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
    Eur J Heart Fail. 2016 Sep 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  138. IBRAHIM I, Kuan WS, Frampton C, Troughton R, et al
    Superior performance of N-terminal pro brain natriuretic peptide for diagnosis of acute decompensated heart failure in an Asian compared with a Western setting.
    Eur J Heart Fail. 2016 Sep 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  139. ADELBORG K, Horvath-Puho E, Ording A, Pedersen L, et al
    Heart failure and risk of dementia: a Danish nationwide population-based cohort study.
    Eur J Heart Fail. 2016 Sep 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  140. OMERSA D, Farkas J, Erzen I, Lainscak M, et al
    National trends in heart failure hospitalization rates in Slovenia 2004-2012.
    Eur J Heart Fail. 2016 Sep 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  141. SHAHID F, Shantsila E, Lip GY
    Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?
    Eur J Heart Fail. 2016;18:1172-4.
    PubMed     Text format    


  142. HAWKINS NM, Jhund PS, Pozzi A, O'Meara E, et al
    Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment.
    Eur J Heart Fail. 2016;18:1162-71.
    PubMed     Text format     Abstract available


    August 2016
  143. BORIANI G, Da Costa A, Quesada A, Ricci RP, et al
    Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial.
    Eur J Heart Fail. 2016 Aug 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  144. JESSUP M
    The BA-HEF trial in Africa: a welcome addition to heart failure history.
    Eur J Heart Fail. 2016 Aug 10. doi: 10.1002.
    PubMed     Text format    


  145. PACKER M
    Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA.
    Eur J Heart Fail. 2016 Aug 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  146. KAPELIOS CJ, Malliaras K, Nanas JN
    Dosing of loop diuretics in chronic heart failure: it's time for evidence.
    Eur J Heart Fail. 2016 Aug 5. doi: 10.1002.
    PubMed     Text format    


  147. PINTALHAO M, Castro-Chaves P, Vasques-Novoa F, Goncalves F, et al
    Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload.
    Eur J Heart Fail. 2016 Aug 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  148. THUM T
    Novel models and mechanisms of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016;18:998-9.
    PubMed     Text format    


  149. METRA M
    August 2016 at a glance: the new ESC guidelines, and pathophysiology, epidemiology and prognosis of heart failure.
    Eur J Heart Fail. 2016;18:889-90.
    PubMed     Text format    


    July 2016
  150. YE S, Qian M, Zhao B, Buchsbaum R, et al
    CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.
    Eur J Heart Fail. 2016 Jul 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  151. BAEZA-TRINIDAD R, Mosquera-Lozano JD, El Bikri L
    Assessment of bendopnoea impact on decompensated heart failure.
    Eur J Heart Fail. 2016 Jul 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  152. DAMMAN K, Solomon SD, Pfeffer MA, Swedberg K, et al
    Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme.
    Eur J Heart Fail. 2016 Jul 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  153. LINDE C, Eriksson MJ, Hage C, Wallen H, et al
    Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants.
    Eur J Heart Fail. 2016 Jul 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  154. DELGADO JF, Bueno H
    Heart failure: health is priceless... but still expensive.
    Eur J Heart Fail. 2016 Jul 4. doi: 10.1002.
    PubMed     Text format    


  155. LUO N, Mentz RJ
    A Gordian knot: disentangling comorbidities in heart failure.
    Eur J Heart Fail. 2016 Jul 4. doi: 10.1002.
    PubMed     Text format    


  156. NUNEZ J, Garcia-Blas S, Comin-Colet J
    Iron deficiency and risk of early readmission following hospitalization for acute heart failure. Reply.
    Eur J Heart Fail. 2016;18:881.
    PubMed     Text format    


  157. MCDONAGH TA
    Ironing out iron deficiency in heart failure.
    Eur J Heart Fail. 2016;18:796-7.
    PubMed     Text format    


    June 2016
  158. SOLOMON SD, Claggett B, McMurray JJ, Hernandez AF, et al
    Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.
    Eur J Heart Fail. 2016 Jun 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  159. TRIPOSKIADIS F, Giamouzis G, Parissis J, Starling RC, et al
    Reframing the association and significance of co-morbidities in heart failure.
    Eur J Heart Fail. 2016 Jun 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  160. MAGNANI G, Giugliano RP, Ruff CT, Murphy SA, et al
    Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.
    Eur J Heart Fail. 2016 Jun 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  161. VADUGANATHAN M, Patel RB, Greene SJ, Gheorghiade M, et al
    Targeting the vulnerable phase of heart failure: initiate novel therapies in stable patients prior to hospitalization.
    Eur J Heart Fail. 2016 Jun 23. doi: 10.1002.
    PubMed     Text format    


  162. BAUERSACHS J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, et al
    Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
    Eur J Heart Fail. 2016 Jun 23. doi: 10.1002.
    PubMed     Text format    


  163. BRAUNSCHWEIG F, Linde C, Benson L, Stahlberg M, et al
    New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
    Eur J Heart Fail. 2016 Jun 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  164. ZAMORA E, Lupon J, Enjuanes C, Pascual-Figal D, et al
    No benefit from the obesity paradox for diabetic patients with heart failure.
    Eur J Heart Fail. 2016 Jun 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  165. EMAMI A, von Haehling S
    Iron deficiency and risk of early readmission following hospitalization for acute heart failure.
    Eur J Heart Fail. 2016 Jun 13. doi: 10.1002.
    PubMed     Text format    


  166. RUTTEN FH, Guder G
    The role of beta-blockers in outcomes of patients hospitalized for heart failure and chronic obstructive pulmonary disease.
    Eur J Heart Fail. 2016 Jun 12. doi: 10.1002.
    PubMed     Text format    


  167. VARDENY O, Claggett B, Packer M, Zile MR, et al
    Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.
    Eur J Heart Fail. 2016 Jun 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  168. CHRIST M, Stork S, Dorr M, Heppner HJ, et al
    Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System.
    Eur J Heart Fail. 2016 Jun 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  169. ANKER SD, Schroeder S, Atar D, Bax JJ, et al
    Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].
    Eur J Heart Fail. 2016;18:727.
    PubMed     Text format    


  170. PARISSIS J, Farmakis D, Triposkiadis F
    Heart failure registries: how far can we go?
    Eur J Heart Fail. 2016;18:626-8.
    PubMed     Text format    


  171. CRESPO-LEIRO MG, Anker SD, Maggioni AP, Coats AJ, et al
    European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
    Eur J Heart Fail. 2016;18:613-25.
    PubMed     Text format     Abstract available


  172. METRA M
    June 2016 at a glance: epidemiology, renal impairment, heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016;18:587.
    PubMed     Text format    


    May 2016
  173. ALTA S, Onat A, Kaya A
    Shared underlying dynamics between heart failure and cancer: autoimmune activation?
    Eur J Heart Fail. 2016 May 30. doi: 10.1002.
    PubMed     Text format    


  174. VIDAN MT, Bueno H
    Trends in heart failure: going in the right direction?
    Eur J Heart Fail. 2016 May 25. doi: 10.1002.
    PubMed     Text format    


  175. RILEY JP, Astin F, Crespo-Leiro MG, Deaton CM, et al
    Heart Failure Association of the European Society of Cardiology heart failure nurse curriculum.
    Eur J Heart Fail. 2016 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  176. FARMAKIS D, Koeck T, Mullen W, Parissis J, et al
    Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates.
    Eur J Heart Fail. 2016 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  177. KAJIMOTO K, Sato N, Takano T
    Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction.
    Eur J Heart Fail. 2016 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  178. KOMAJDA M, Tavazzi L, Swedberg K, Bohm M, et al
    Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT.
    Eur J Heart Fail. 2016 May 22. doi: 10.1002.
    PubMed     Text format     Abstract available



  179. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribut
    Eur J Heart Fail. 2016 May 20. doi: 10.1002.
    PubMed     Text format    


  180. ANTMAN EM, Bax J, Chazal RA, Creager MA, et al
    Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.
    Eur J Heart Fail. 2016 May 20. doi: 10.1002.
    PubMed     Text format    


  181. SLIWA K, Damasceno A, Davison BA, Mayosi BM, et al
    Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF).
    Eur J Heart Fail. 2016 May 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  182. TOKITSU T, Yamamoto E, Hirata Y, Kusaka H, et al
    Clinical significance of pulse pressure in patients with heart failure with preserved left ventricular ejection fraction.
    Eur J Heart Fail. 2016 May 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  183. CANNON JA, Shen L, Jhund PS, Anand IS, et al
    Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
    Eur J Heart Fail. 2016 May 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  184. ZAFRIR B, Salman N, Crespo-Leiro MG, Anker SD, et al
    Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2016 May 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  185. SENNI M, McMurray JJ, Wachter R, McIntyre HF, et al
    Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.
    Eur J Heart Fail. 2016 May 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  186. BIEGUS J, Hillege HL, Postmus D, Valente MA, et al
    Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
    Eur J Heart Fail. 2016 May 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  187. GOUDA P, Brown P, Rowe BH, McAlister FA, et al
    Insights into the importance of the electrocardiogram in patients with acute heart failure.
    Eur J Heart Fail. 2016 May 5. doi: 10.1002.
    PubMed     Text format     Abstract available


  188. PRIMESSNIG U, Schonleitner P, Holl A, Pfeiffer S, et al
    Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 May 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  189. BAYES-GENIS A, Barallat J, Lupon J
    Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction?
    Eur J Heart Fail. 2016;18:576.
    PubMed     Text format    


  190. VAN AELST LN, Celutkiene J, Mebazaa A
    Advanced heart failure: look right to prognosticate right!
    Eur J Heart Fail. 2016;18:573-5.
    PubMed     Text format    


  191. CLARK AL
    Tipping the scales toward fitness as a key modifier of the obesity paradox in heart failure.
    Eur J Heart Fail. 2016;18:554-5.
    PubMed     Text format    


  192. PIEPOLI MF, Corra U, Veglia F, Bonomi A, et al
    Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group.
    Eur J Heart Fail. 2016;18:545-53.
    PubMed     Text format     Abstract available


  193. MAGGIONI AP, Piepoli MF
    The European Society of Cardiology Heart Failure Association Annual Congress.
    Eur J Heart Fail. 2016;18:454-5.
    PubMed     Text format    


  194. OZKAN J
    Frank Ruschitzka MD FESC FRCP shares some thoughts on the future direction of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2016;18:453-4.
    PubMed     Text format    


  195. OZKAN J
    Gerasimos Filippatos MD FESC FHFA, outgoing president of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2016;18:452-3.
    PubMed     Text format    



  196. Abstracts of the Heart Failure 2016 Conference, Florence, Italy, 21-24 May 2016.
    Eur J Heart Fail. 2016;18 Suppl 1:8-521.
    PubMed     Text format    


    April 2016
  197. NAGAI T, Nishimura K, Honma T, Higashiyama A, et al
    Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure.
    Eur J Heart Fail. 2016 Apr 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  198. VOORS AA, Anker SD, Cleland JG, Dickstein K, et al
    A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
    Eur J Heart Fail. 2016 Apr 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  199. MAHFOUD F, Ewen S, Bohm M
    Renal denervation in patients with heart failure with preserved ejection fraction: end of the beginning?
    Eur J Heart Fail. 2016 Apr 27. doi: 10.1002.
    PubMed     Text format    


  200. VADUGANATHAN M, Pallais JC, Fenves AZ, Butler J, et al
    Serum chloride in heart failure: a salty prognosis.
    Eur J Heart Fail. 2016 Apr 27. doi: 10.1002.
    PubMed     Text format    


  201. MAGGIONI AP
    Outcome improvement of patients with heart failure and reduced ejection fraction: has it ended in the new millennium?
    Eur J Heart Fail. 2016 Apr 27. doi: 10.1002.
    PubMed     Text format    


  202. JACKSON CE, Haig C, Welsh P, Dalzell JR, et al
    The incremental prognostic and clinical value of multiple novel biomarkers in heart failure.
    Eur J Heart Fail. 2016 Apr 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  203. DAVISON BA, Metra M, Senger S, Edwards C, et al
    Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Eur J Heart Fail. 2016 Apr 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  204. FARRE N, Vela E, Cleries M, Bustins M, et al
    Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients.
    Eur J Heart Fail. 2016 Apr 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  205. STASZEWSKY L, Cortesi L, Tettamanti M, Dal Bo GA, et al
    Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
    Eur J Heart Fail. 2016 Apr 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  206. VAN VELDHUISEN DJ, de Boer RA
    Ischaemia in heart failure with preserved ejection fraction; is it important?
    Eur J Heart Fail. 2016 Apr 20. doi: 10.1002.
    PubMed     Text format    


  207. KOMAJDA M, Anker SD, Cowie MR, Filippatos GS, et al
    Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
    Eur J Heart Fail. 2016 Apr 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  208. JHUND PS, Tavazzi L
    Has the 'epidemic' of heart failure been replaced by a tsunami of co-morbidities?
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format    


  209. MONNERET D, Roche F, Bonnefont-Rousselot D
    Plasma endothelin-1 in acute heart failure: pathophysiological and preanalytical considerations.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format    


  210. VIDAN MT, Blaya-Novakova V, Sanchez E, Ortiz J, et al
    Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  211. ANKER SD, Schroeder S, Atar D, Bax JJ, et al
    Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  212. ALFALEH H, Elasfar AA, Ullah A, AlHabib KF, et al
    Worsening heart failure in 'real-world' clinical practice: predictors and prognostic impact.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  213. WESTENBRINK BD, Brugts JJ, McDonagh TA, Filippatos G, et al
    Heart failure specialization in Europe.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format    


  214. BORIANI G, Berti E, Belotti LM, Biffi M, et al
    Cardiac device therapy in patients with left ventricular dysfunction and heart failure: 'real-world' data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital).
    Eur J Heart Fail. 2016 Apr 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  215. VOLPE M, Battistoni A, Mastromarino V
    Natriuretic peptides and volume handling in heart failure: the paradigm of a new treatment.
    Eur J Heart Fail. 2016;18:442-4.
    PubMed     Text format    


    March 2016
  216. NUNEZ J, Comin-Colet J, Minana G, Nunez E, et al
    Iron deficiency and risk of early readmission following a hospitalization for acute heart failure.
    Eur J Heart Fail. 2016 Mar 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  217. BUTLER J, Gheorghiade M, Metra M
    Moving away from symptoms-based heart failure treatment: misperceptions and real risks for patients with heart failure.
    Eur J Heart Fail. 2016 Mar 17. doi: 10.1002.
    PubMed     Text format    


  218. SHOAIB A, Farag M, Nasir M, John J, et al
    Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  219. FREA S, Pidello S, Bovolo V, Iacovino C, et al
    Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  220. PATEL HC, Rosen SD, Hayward C, Vassiliou V, et al
    Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trial.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  221. BOHM M, Lloyd SM, Ford I, Borer JS, et al
    Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT.
    Eur J Heart Fail. 2016 Mar 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  222. HARJOLA VP, Mebazaa A, Celutkiene J, Bettex D, et al
    Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.
    Eur J Heart Fail. 2016;18:226-41.
    PubMed     Text format     Abstract available


  223. METRA M
    March 2016 at a glance. Focus on right ventricular failure and acute heart failure.
    Eur J Heart Fail. 2016;18:225.
    PubMed     Text format    


    February 2016
  224. THORVALDSEN T, Benson L, Dahlstrom U, Edner M, et al
    Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  225. VEGTER EL, van der Meer P, de Windt LJ, Pinto YM, et al
    MicroRNAs in heart failure: from biomarker to target for therapy.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  226. PEARSE SG, Cowie MR
    Sleep-disordered breathing in heart failure.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  227. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  228. TER MAATEN JM, Damman K, Verhaar MC, Paulus WJ, et al
    Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
    Eur J Heart Fail. 2016 Feb 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  229. CHIN KL, Collier TJ, Pitt B, McMurray JJ, et al
    Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study.
    Eur J Heart Fail. 2016 Feb 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  230. VON HAEHLING S
    Adding insult to injury: heart failure and incident cancer.
    Eur J Heart Fail. 2016 Feb 1. doi: 10.1002.
    PubMed     Text format    



  231. Corrigendum to 'What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative'[Eur J Heart Fail 2016; 18:66-70].
    Eur J Heart Fail. 2016;18:217.
    PubMed     Text format    


  232. GILBERT RE, Ruschitzka F
    Henry Krum, Pioneering Heart Failure Researcher.
    Eur J Heart Fail. 2016;18:125-6.
    PubMed     Text format    


  233. SINAGRA G, Fabris E
    Direct cellular reprogramming: the hopes and the hurdles.
    Eur J Heart Fail. 2016;18:157-9.
    PubMed     Text format    


  234. VERBRUGGE FH
    Decongestion: more than meets the eye!
    Eur J Heart Fail. 2016;18:192-4.
    PubMed     Text format    


  235. METRA M
    February 2016 at a glance. Focus issue on cardiac regeneration, medical treatment and cardiac devices.
    Eur J Heart Fail. 2016;18:127.
    PubMed     Text format    


  236. VADUGANATHAN M, Prasad V
    Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication?
    Eur J Heart Fail. 2016;18:128-32.
    PubMed     Text format    


  237. STOLFO D, Tonet E, Merlo M, Barbati G, et al
    Early right ventricular response to cardiac resynchronization therapy: impact on clinical outcomes.
    Eur J Heart Fail. 2016;18:205-13.
    PubMed     Text format     Abstract available


  238. BATTY JA, Lima JA Jr, Kunadian V
    Direct cellular reprogramming for cardiac repair and regeneration.
    Eur J Heart Fail. 2016;18:145-56.
    PubMed     Text format     Abstract available


  239. SCHUSSLER-LENZ M, Beuneu C, Menezes-Ferreira M, Jekerle V, et al
    Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints.
    Eur J Heart Fail. 2016;18:133-41.
    PubMed     Text format     Abstract available


  240. VADUGANATHAN M, Goldsmith SR, Senni M, Butler J, et al
    Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial.
    Eur J Heart Fail. 2016;18:185-91.
    PubMed     Text format     Abstract available


    January 2016
  241. PARISSIS J, Farmakis D, Kadoglou N, Ikonomidis I, et al
    Body mass index in acute heart failure: association with clinical profile, therapeutic management and in-hospital outcome.
    Eur J Heart Fail. 2016 Jan 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  242. STARLING RC
    Augmenting outcomes in advanced heart failure: a lot to learn.
    Eur J Heart Fail. 2016 Jan 28. doi: 10.1002.
    PubMed     Text format    


  243. JANKOWSKA EA, Tkaczyszyn M, Suchocki T, Drozd M, et al
    Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
    Eur J Heart Fail. 2016 Jan 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  244. WONG YW, Mentz RJ, Felker GM, Ezekowitz J, et al
    Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials.
    Eur J Heart Fail. 2016 Jan 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  245. KLERSY C, Boriani G, De Silvestri A, Mairesse GH, et al
    Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized, controlled trials in patients with heart failure.
    Eur J Heart Fail. 2016 Jan 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  246. MCKIE PM, Schirger JA, Benike SL, Harstad LK, et al
    Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure.
    Eur J Heart Fail. 2016 Jan 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  247. DIAS A, Franco E
    A position statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology: What about racial differences?
    Eur J Heart Fail. 2016 Jan 21. doi: 10.1002.
    PubMed     Text format    


  248. TERZIC A, Behfar A, Filippatos G
    Clinical development plan for regenerative therapy in heart failure.
    Eur J Heart Fail. 2016 Jan 21. doi: 10.1002.
    PubMed     Text format    


  249. GROTE BEVERBORG N, van der Wal HH, Klip IT, Voors AA, et al
    High serum erythropoietin levels are related to heart failure development in subjects from the general population with albuminuria: data from PREVEND.
    Eur J Heart Fail. 2016 Jan 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  250. TEKTONIDIS TG, Akesson A, Gigante B, Wolk A, et al
    Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men.
    Eur J Heart Fail. 2016 Jan 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  251. TESTANI JM, Hanberg JS, Arroyo JP, Brisco MA, et al
    Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure.
    Eur J Heart Fail. 2016 Jan 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  252. MAGGIONI AP, Orso F, Calabria S, Rossi E, et al
    The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database.
    Eur J Heart Fail. 2016 Jan 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  253. BANKE A, Schou M, Videbaek L, Moller JE, et al
    Incidence of cancer in patients with chronic heart failure: a long-term follow-up study.
    Eur J Heart Fail. 2016 Jan 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  254. SUEMATSU Y, Miura SI, Goto M, Matsuo Y, et al
    LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice.
    Eur J Heart Fail. 2016 Jan 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  255. RUIZ-ESPARZA GU, Segura-Ibarra V, Cordero-Reyes AM, Youker KA, et al
    A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics.
    Eur J Heart Fail. 2016 Jan 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  256. VAN RIET EE, Hoes AW, Wagenaar KP, Limburg A, et al
    Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  257. COIRO S, Chouihed T, Girerd N
    Lung ultrasound - The extension of clinical examination in patients with acute heart failure: Reply.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format    


  258. KAMPERIDIS V, Delgado V, van Mieghem NM, Kappetein AP, et al
    Diagnosis and management of aortic valve stenosis in patients with heart failure.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  259. GOLIASCH G, Pavo N, Zotter-Tufaro C, Kammerlander A, et al
    Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  260. RIZZI MA, Alquezar A, Marcuello JM, Ontiveros HH, et al
    The Redin SCORE: useful, but not for all.
    Eur J Heart Fail. 2016;18:116.
    PubMed     Text format    


  261. ALVAREZ-GARCIA J, Ferrero-Gregori A, Puig T, Cinca J, et al
    The Redin SCORE: useful, but not for all: reply.
    Eur J Heart Fail. 2016;18:117.
    PubMed     Text format    


  262. BRAMLAGE P, Swift SL, Thoenes M, Minguet J, et al
    Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease.
    Eur J Heart Fail. 2016;18:28-37.
    PubMed     Text format     Abstract available


    December 2015
  263. TER MAATEN JM, Voors AA
    Renal dysfunction in heart failure with a preserved ejection fraction: cause or consequence?
    Eur J Heart Fail. 2015 Dec 28. doi: 10.1002.
    PubMed     Text format    


  264. SAMSKY MD, Dunning A, DeVore AD, Schulte PJ, et al
    Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
    Eur J Heart Fail. 2015 Dec 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  265. DAMMAN K, Kjekshus J, Wikstrand J, Cleland JG, et al
    Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Eur J Heart Fail. 2015 Dec 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  266. BHANDARI SS, Narayan H, Jones DJ, Suzuki T, et al
    Plasma growth hormone is a strong predictor of risk at 1 year in acute heart failure.
    Eur J Heart Fail. 2015 Dec 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  267. HAWKINS NM, Virani SA, Sperrin M, Buchan IE, et al
    Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges.
    Eur J Heart Fail. 2015 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  268. PEREZ AL, Grodin JL, Wu Y, Hernandez AF, et al
    Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy.
    Eur J Heart Fail. 2015 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  269. BARTUNEK J, Davison B, Sherman W, Povsic T, et al
    Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.
    Eur J Heart Fail. 2015 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  270. ELDER DH, Singh JS, Levin D, Donnelly LA, et al
    Mean HbA and mortality in diabetic individuals with heart failure: a population cohort study.
    Eur J Heart Fail. 2015 Dec 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  271. UNGER ED, Dubin RF, Deo R, Daruwalla V, et al
    Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  272. DEMISSEI BG, Cleland JG, O'Connor CM, Metra M, et al
    Optimizing clinical use of biomarkers in high-risk acute heart failure patients.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  273. VADUGANATHAN M, Michel A, Hall K, Mulligan C, et al
    Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  274. PITT B, Weir MR
    Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format    


  275. SPERANDEO M, Di Stolfo G, Carnevale V
    'B line' in heart failure: a not so easy issue.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format    



  276. Corrigendum to 'Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart' [Eur J Heart Fail] 2015 August;17(8): 760-763. doi:10.1002/ejhf.315.
    Eur J Heart Fail. 2015;17:1317.
    PubMed     Text format    


  277. VAN DER WAL HH, Cowie MR, van der Meer P
    Sleep-disordered breathing and chronic heart failure: changing position may be important.
    Eur J Heart Fail. 2015;17:1219-22.
    PubMed     Text format    


  278. VESCOVO G
    Neuromuscular junction fragmentation and muscle wasting in heart failure: a sharp cut from a Sica sword?
    Eur J Heart Fail. 2015;17:1216-8.
    PubMed     Text format    


    November 2015
  279. MANN DL, Lee RJ, Coats AJ, Neagoe G, et al
    One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure.
    Eur J Heart Fail. 2015 Nov 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  280. LYON AR, Bossone E, Schneider B, Sechtem U, et al
    Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2015 Nov 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  281. RICHARDS AM, Frampton CM
    Can circulating biomarkers identify heart failure patients at low risk?
    Eur J Heart Fail. 2015 Nov 4. doi: 10.1002.
    PubMed     Text format    


  282. VOLPE M, Santolamazza C, Mastromarino V
    Erythropoiesis-stimulating agents in heart failure: leave it or re-take it?
    Eur J Heart Fail. 2015 Nov 3. doi: 10.1002.
    PubMed     Text format    


    October 2015
  283. STORK S, Kavoliuniene A, Vinereanu D, Ludwig R, et al
    What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative.
    Eur J Heart Fail. 2015 Oct 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  284. EMMENS JE, Ter Maaten JM, Matsue Y, Metra M, et al
    Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
    Eur J Heart Fail. 2015 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  285. SAHLE BW, Owen AJ, Krum H, Reid CM, et al
    Incidence of heart failure in 6083 elderly hypertensive patients: the Second Australian National Blood Pressure Study (ANBP2).
    Eur J Heart Fail. 2015 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  286. DESTA L, Jernberg T, Spaak J, Hofman-Bang C, et al
    Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91 360 patients admitted with index myocardial infarction between 1998 and 2010.
    Eur J Heart Fail. 2015 Oct 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  287. CHAN MM, Santhanakrishnan R, Chong JP, Chen Z, et al
    Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Eur J Heart Fail. 2015 Oct 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  288. D'ELIA E, Vaduganathan M, Gori M, Gavazzi A, et al
    Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.
    Eur J Heart Fail. 2015 Oct 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  289. SANDERS-VAN WIJK S, van Empel V, Davarzani N, Maeder MT, et al
    Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Eur J Heart Fail. 2015 Oct 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  290. GARGANI L
    Prognosis in heart failure: look at the lungs.
    Eur J Heart Fail. 2015 Oct 16. doi: 10.1002.
    PubMed     Text format    


  291. FERRE RM, Chioncel O, Pang PS, Lang RM, et al
    Acute heart failure: the role of focused emergency cardiopulmonary ultrasound in identification and early management.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format    


  292. AMBROSY AP, Hernandez AF, Armstrong PW, Butler J, et al
    The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  293. MELENOVSKY V, Andersen MJ, Andress K, Reddy YN, et al
    Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  294. PINNA GD, Robbi E, La Rovere MT, Taurino AE, et al
    Differential impact of body position on the severity of disordered breathing in heart failure patients with obstructive vs. central sleep apnoea.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  295. PARISSIS J, Farmakis D, Karavidas A, Arapi S, et al
    Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure: practical considerations and proposed algorithm.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format    


  296. MEIJERS WC, de Boer RA, van Veldhuisen DJ, Jaarsma T, et al
    Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  297. PITT B, Bakris GL, Bushinsky DA, Garza D, et al
    Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors.
    Eur J Heart Fail. 2015 Oct 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  298. ASCHAUER S, Kammerlander AA, Zotter-Tufaro C, Ristl R, et al
    The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics.
    Eur J Heart Fail. 2015 Oct 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  299. STEINBECK L, Ebner N, Valentova M, Bekfani T, et al
    Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
    Eur J Heart Fail. 2015 Oct 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  300. KONSTAM MA
    Hyperkalaemia in heart failure: binding the patient to improved treatment?
    Eur J Heart Fail. 2015 Oct 7. doi: 10.1002.
    PubMed     Text format    


  301. VON LUEDER TG, Girerd N, Atar D, Agewall S, et al
    Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
    Eur J Heart Fail. 2015 Oct 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  302. WAGENAAR KP, Broekhuizen BD, Dickstein K, Jaarsma T, et al
    Effectiveness of an interactive platform, and the ESC/HFA heartfailurematters.org website in patients with heart failure: design of the multicentre randomized e-Vita heart failure trial.
    Eur J Heart Fail. 2015 Oct 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  303. BELLO NA, Lewis EF, Desai AS, Anand IS, et al
    Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease.
    Eur J Heart Fail. 2015 Oct 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  304. KRUM H, McMurray JJ, Abraham WT, Dickstein K, et al
    The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics.
    Eur J Heart Fail. 2015;17:1075-83.
    PubMed     Text format     Abstract available


  305. ANSELMINO M, Matta M, Gaita F
    Catheter ablation of atrial fibrillation in patients with heart failure: can we break the vicious circle?
    Eur J Heart Fail. 2015;17:1003-5.
    PubMed     Text format    


    September 2015
  306. BRUNNER-LA ROCCA HP, Eurlings L, Richards AM, Januzzi JL, et al
    Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
    Eur J Heart Fail. 2015 Sep 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  307. TEIXEIRA A, Parenica J, Park JJ, Ishihara S, et al
    Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort.
    Eur J Heart Fail. 2015 Sep 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  308. COIRO S, Rossignol P, Ambrosio G, Carluccio E, et al
    Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure.
    Eur J Heart Fail. 2015 Sep 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  309. BANG C, Antoniades C, Antonopoulos AS, Eriksson U, et al
    Intercellular communication lessons in heart failure.
    Eur J Heart Fail. 2015 Sep 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  310. BRAUNWALD E
    Another step toward personalized care of patients with heart failure.
    Eur J Heart Fail. 2015 Sep 16. doi: 10.1002.
    PubMed     Text format    


  311. KOMAJDA M, Tavazzi L, Francq BG, Bohm M, et al
    Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.
    Eur J Heart Fail. 2015 Sep 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  312. GREENE SJ, Fonarow GC
    Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction?
    Eur J Heart Fail. 2015 Sep 16. doi: 10.1002.
    PubMed     Text format    


  313. SIMPSON J, Castagno D, Doughty RN, Poppe KK, et al
    Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.
    Eur J Heart Fail. 2015 Sep 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  314. OVCHINNIKOVA ES, Schmitter D, Vegter EL, Ter Maaten JM, et al
    Signature of circulating microRNAs in patients with acute heart failure.
    Eur J Heart Fail. 2015 Sep 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  315. XIONG Q, Lau YC, Senoo K, Lane DA, et al
    Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.
    Eur J Heart Fail. 2015 Sep 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  316. MICHAEL FELKER G, Mentz RJ, Teerlink JR, Voors AA, et al
    Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study.
    Eur J Heart Fail. 2015 Sep 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  317. COTTER G, Voors AA, Prescott MF, Felker GM, et al
    Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.
    Eur J Heart Fail. 2015 Sep 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  318. FELKER GM, Ahmad T
    Reclassifying heart failure: time for disruptive innovation?
    Eur J Heart Fail. 2015 Sep 2. doi: 10.1002.
    PubMed     Text format    


    August 2015
  319. LIP GY, Heinzel FR, Gaita F, Juanatey JR, et al
    European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
    Eur J Heart Fail. 2015 Aug 21. doi: 10.1002.
    PubMed     Text format    


  320. PELLICORI P, Clark AL
    Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure.
    Eur J Heart Fail. 2015 Aug 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  321. GREENE SJ, Gheorghiade M
    Same protocol, different continents, different patients: should we continue to conduct global heart failure trials?
    Eur J Heart Fail. 2015 Aug 20. doi: 10.1002.
    PubMed     Text format    


  322. KAO DP, Lewsey JD, Anand IS, Massie BM, et al
    Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
    Eur J Heart Fail. 2015 Aug 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  323. BUTLER J, Gheorghiade M, Kelkar A, Fonarow GC, et al
    In-hospital worsening heart failure.
    Eur J Heart Fail. 2015 Aug 3. doi: 10.1002.
    PubMed     Text format     Abstract available


    July 2015
  324. PLATZ E, Jhund PS, Campbell RT, McMurray JJ, et al
    Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review.
    Eur J Heart Fail. 2015 Jul 31. doi: 10.1002.
    PubMed     Text format     Abstract available


  325. STIENEN S, Salah K, Eurlings LW, Bettencourt P, et al
    Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro a brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
    Eur J Heart Fail. 2015 Jul 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  326. SHIMOKAWA H, Miura M, Nochioka K, Sakata Y, et al
    Heart failure as a general pandemic in Asia.
    Eur J Heart Fail. 2015 Jul 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  327. VAGNARELLI F, Corsini A, Lorenzini M, Pacini D, et al
    Acute heart failure in patients with acute aortic syndrome: pathophysiology and clinical-prognostic implications.
    Eur J Heart Fail. 2015 Jul 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  328. VERBRUGGE FH, Dupont M, Finucan M, Gabi A, et al
    Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure.
    Eur J Heart Fail. 2015 Jul 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  329. FERREIRA JP, Girerd N, Rossignol P, Zannad F, et al
    Geographic differences in heart failure trials.
    Eur J Heart Fail. 2015 Jul 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  330. SCHERBAKOV N, Bauer M, Sandek A, Szabo T, et al
    Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Eur J Heart Fail. 2015 Jul 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  331. LATINI R, Masson S
    Understanding and making good use of changes in natriuretic peptide levels in chronic heart failure.
    Eur J Heart Fail. 2015 Jul 15. doi: 10.1002.
    PubMed     Text format    


  332. SENNI M, Gavazzi A, Gheorghiade M, Butler J, et al
    Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart.
    Eur J Heart Fail. 2015 Jul 15. doi: 10.1002.
    PubMed     Text format    


  333. WOLSK E, Lamberts M, Hansen ML, Blanche P, et al
    Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study.
    Eur J Heart Fail. 2015 Jul 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  334. JAARSMA T, Klompstra L, Ben Gal T, Boyne J, et al
    Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF-Wii study; a multicentre randomized controlled trial.
    Eur J Heart Fail. 2015;17:743-8.
    PubMed     Text format     Abstract available


  335. CANNON JA, Collier TJ, Shen L, Swedberg K, et al
    Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).
    Eur J Heart Fail. 2015;17:707-16.
    PubMed     Text format     Abstract available


  336. LEDWIDGE MT, O'Connell E, Gallagher J, Tilson L, et al
    Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study.
    Eur J Heart Fail. 2015;17:672-9.
    PubMed     Text format     Abstract available


  337. HOTHI SS, Tan LB, Cotter G
    Resting cardiac power index and prediction of prognosis in heart failure.
    Eur J Heart Fail. 2015;17:642-4.
    PubMed     Text format    


    June 2015
  338. MONTERO-PEREZ-BARQUERO M, Formiga F, Manzano L
    About the RICA registry in patients with heart failure.
    Eur J Heart Fail. 2015 Jun 24. doi: 10.1002.
    PubMed     Text format    


  339. HAUPTMAN PJ
    Addressing disparities in heart failure care without borders.
    Eur J Heart Fail. 2015 Jun 17. doi: 10.1002.
    PubMed     Text format    


  340. MENTZ RJ, Metra M, Cotter G, Milo O, et al
    Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial.
    Eur J Heart Fail. 2015 Jun 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  341. FERRARI R, Bohm M, Cleland JG, Paulus WJ, et al
    Heart failure with preserved ejection fraction: uncertainties and dilemmas.
    Eur J Heart Fail. 2015 Jun 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  342. PARISSIS J, Farmakis D, Lekakis J, Filippatos G, et al
    Overcoming the ethnic differences in patients hospitalized for heart failure: is there a need for international harmonization of clinical practice guidelines?
    Eur J Heart Fail. 2015 Jun 4. doi: 10.1002.
    PubMed     Text format    


  343. MEBAZAA A, Longrois D, Metra M, Mueller C, et al
    Agents with vasodilator properties in acute heart failure: how to design successful trials.
    Eur J Heart Fail. 2015 Jun 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  344. PARK JJ, Choi DJ, Yoon CH, Oh IY, et al
    The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean Heart Failure (KorHF) registry.
    Eur J Heart Fail. 2015;17:601-11.
    PubMed     Text format     Abstract available


  345. GRIGIONI F, Senni M
    The Pilot European Survey of Atrial Fibrillation: how to look at heart failure through a keyhole.
    Eur J Heart Fail. 2015;17:541-3.
    PubMed     Text format    


  346. KARPER JC, Westenbrink BD
    BNP in heart failure: even leucocytes cannot escape its influence.
    Eur J Heart Fail. 2015;17:536-8.
    PubMed     Text format    


    May 2015
  347. DONAL E, Lund LH, Oger E, Hage C, et al
    New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Eur J Heart Fail. 2015 May 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  348. DI TANO G, De Maria R, Gonzini L, Aspromonte N, et al
    The 30-day metric in acute heart failure revisited: data from IN-HF Outcome, an Italian nationwide cardiology registry.
    Eur J Heart Fail. 2015 May 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  349. MACDONALD MR, She L, Doenst T, Binkley PF, et al
    Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
    Eur J Heart Fail. 2015 May 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  350. ZILE MR, Abraham WT, Weaver FA, Butter C, et al
    Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy.
    Eur J Heart Fail. 2015 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  351. ANKER SD, Kosiborod M, Zannad F, Pina IL, et al
    Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.
    Eur J Heart Fail. 2015 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  352. ALVAREZ-GARCIA J, Ferrero-Gregori A, Puig T, Vazquez R, et al
    A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients: the Redin-SCORE.
    Eur J Heart Fail. 2015 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  353. HARIKRISHNAN S, Sanjay G, Anees T, Viswanathan S, et al
    Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry.
    Eur J Heart Fail. 2015 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  354. MEBAZAA A, Birhan Yilmaz M, Levy P, Ponikowski P, et al
    Recommendations on pre-hospital & hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emerge
    Eur J Heart Fail. 2015 May 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  355. GOTSMAN I, Avishai-Eliner S, Jabara R, Zemora Z, et al
    Ethnic disparity in the clinical characteristics of patients with heart failure.
    Eur J Heart Fail. 2015 May 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  356. KHAN H, Greene SJ, Fonarow GC, Kalogeropoulos AP, et al
    Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.
    Eur J Heart Fail. 2015 May 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  357. RUGGENENTI P, Remuzzi G
    Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart?
    Eur J Heart Fail. 2015;17:468-71.
    PubMed     Text format    


  358. METRA M
    May 2015 at a glance.
    Eur J Heart Fail. 2015;17:465.
    PubMed     Text format    


  359. HARJOLA VP, Lassus J, Sionis A, Kober L, et al
    Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
    Eur J Heart Fail. 2015;17:501-9.
    PubMed     Text format     Abstract available


    April 2015
  360. SCHMITTER D, Voors AA, van der Harst P
    HFpEF vs. HFrEF: can microRNAs advance the diagnosis?
    Eur J Heart Fail. 2015;17:351-4.
    PubMed     Text format    


  361. METRA M
    April 2015 at a glance.
    Eur J Heart Fail. 2015;17:347.
    PubMed     Text format    


    March 2015
  362. PONIKOWSKI P, Filippatos G, Colet JC, Willenheimer R, et al
    The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.
    Eur J Heart Fail. 2015;17:329-39.
    PubMed     Text format     Abstract available


  363. LAM CS, McEntegart M, Claggett B, Liu J, et al
    Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    Eur J Heart Fail. 2015;17:301-12.
    PubMed     Text format     Abstract available


    January 2015
  364. JOYCE E, Ninaber MK, Katsanos S, Debonnaire P, et al
    Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis.
    Eur J Heart Fail. 2015;17:51-62.
    PubMed     Text format     Abstract available


    December 2014
  365. MAOR E, Grossman Y, Balmor RG, Segel M, et al
    Exercise haemodynamics may unmask the diagnosis of diastolic dysfunction among patients with pulmonary hypertension.
    Eur J Heart Fail. 2014 Dec 8. doi: 10.1002.
    PubMed     Text format     Abstract available


    November 2014
  366. GOUDIE A, Elder D, Deshmukh H, Szwejkowski BR, et al
    Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study.
    Eur J Heart Fail. 2014 Nov 27. doi: 10.1002.
    PubMed     Text format     Abstract available


    September 2014
  367. YU CM, Fang F, Luo XX, Zhang Q, et al
    Long-term follow-up results of the pacing to avoid cardiac enlargement (PACE) trial.
    Eur J Heart Fail. 2014;16:1016-25.
    PubMed     Text format     Abstract available


    April 2014

  368. Abstracts of the 7th Asian Pacific Congress of Heart Failure, 17-19th April 2014, Bali, Indonesia.
    Eur J Heart Fail. 2014;16 Suppl 1:1-41.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: